PharmAust |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 10:22am | ||||
|
Market Cap (13-Nov) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
Monepantel and monepantel sulfone COVID-19 anti-viral update
PAA released this announcement to the ASX on 26 July 2021, 10:26. The announcement is marked as price sensitive, and is 2 page(s) in length and 503.52kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Monepantel and monepantel sulfone COVID-19 anti-viral update | 26 July 2021, 10:26 |
| PharmAust files patent for monepantel in viral diseases | 22 July 2021, 8:16 |
| PharmAust and WEHI to Investigate HTLV-1 Viral Infections | 12 July 2021, 8:23 |
| Science Week Conference Presentation | 9 July 2021, 8:19 |
If you were already registered, log in here.